Time point | Data collection | Measure | Outcomes |
---|---|---|---|
Pre-evaluation | Blood and urine analysis | Glycemia, HbA1c, microalbuminuria and creatinine | Metabolic responses |
Cardiovascular autonomic assessment | Ewing tests | Diagnosis of cardiovascular autonomic neuropathy | |
International Physical Activity Questionnaire | Survey | Physical activity estimates | |
Inspiratory muscle test | maximal inspiratory mouth pressure (PImax) | Inspiratory muscle strength | |
Pulmonary function test | maximum voluntary ventilation, forced vital capacity, vital capacity, forced expiratory volume (1 s), forced expiratory volume (1 s)/vital capacity and forced expiratory volume (1 s)/forced vital capacity | Pulmonary flow and volume | |
Rest electrocardiogram | 12-lead electrocardiogram | Electrical activity of the heart | |
Cardiopulmonary exercise testing | VO2peak, VCO2peak, Rpeak, VEpeak, VE⁄VO2peak, VE⁄VCO2peak | Ventilatory and metabolic variables | |
At rest | Continuous glucose monitoring system | Glucose concentration | Glucose levels and variability |
Biopac system | Continuous recording of blood pressure | Blood pressure and heart rate variability in time and frequency domains | |
Controlled ventilation | Continuous glucose monitoring system | Glucose concentration | Glucose concentration and variability |
Biopac system | Continuous recording of blood pressure | Blood pressure and heart rate variability in time and frequency domains | |
Inspiratory muscle exercise (2 % or 60 % of maximal inspiratory mouth pressure, PImax) | Continuous glucose monitoring system | Glucose concentration | Glucose levels and variability |
Biopac system | Continuous recording of blood pressure | Blood pressure and heart rate variability in time and frequency domains | |
Recuperation | Continuous glucose monitoring system | Glucose concentration | Glucose concentration and variability |
Biopac system | Continuous recording of blood pressure | Blood pressure and heart rate variability in time and frequency domains |